Plasticell and EMD Millipore complete licensing deal to distribute fully defined, xeno-free mesenchymal stem cell differentiation media

16-08-2012: Plasticell has licensed EMD Millipore to distribute a superior, single-application osteogenic medium discovered using the combinatorial screening system, CombiCult®.

The osteogenic medium is serum- and xeno- free, more consistent and more potent than currently available formulations. Under the terms of the contract, EMD Millipore has secured a license to distribute the medium globally for research purposes with Plasticell retaining full rights over therapeutic applications.